Global Advanced Medical Stopcock Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) The factors that drive the Medical Stopcock market include high demand for valves in the healthcare sector, development in research & development activities to design their products in accordance with changing requirements in various industries, large numbers of... more

Global Die and Mould Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Moulds (or molds) and dies are used to make a variety of objects with many different media. For instance, plastic plumbing pipes can me made in a mould; tools such as wrenches are cast in dies. Moulds tend to be used to produce products that need to be hollow in... more

Global Besponsa Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Besponsa is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). According to this study, over the next five years the Besponsa market will register a xx% CAGR in terms of revenue, the global market... more

Global Inotuzumab Ozogamicin Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Inotuzumab ozogamicin is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). According to this study, over the next five years the Inotuzumab Ozogamicin market will register a xx% CAGR in terms of... more

Global Atriance Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Atriance is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. According to this study, over the next five years the Atriance market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$... more

Global Arranon Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Arranon is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. According to this study, over the next five years the Arranon market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx... more

Global Nelarabine Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Nelarabine is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. According to this study, over the next five years the Nelarabine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from... more

Global Swedish Porphyria Therapeutics Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. According to this study, over the next five years the... more

Global Swedish Porphyria Treatment Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. According to this study, over the next five years the... more

Global Swedish Porphyria Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. According to this study, over the next five years the... more

Global Acute Intermittent Porphyria Therapeutics Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It... more

Global Acute Intermittent Porphyria Treatment Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It... more

Global Acute Intermittent Porphyria Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It... more

Global Swedish Porphyria Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. According to this study, over the next five years the... more

Global Panhematin Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Panhematin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. According to this study, over the next five years the Panhematin Drugs market will register a xx% CAGR in terms... more